[1] |
Léauté⁃Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma[J]. Lancet, 2017,390(10089):85⁃94. doi: 10.1016/S0140⁃6736(16)00645⁃0.
|
[2] |
Rodríguez Bandera AI, Sebaratnam DF, Wargon O, et al. Infantile hemangioma. Part 1: epidemiology, pathogenesis, clinical presentation and assessment[J]. J Am Acad Dermatol, 2021,85(6):1379⁃1392. doi: 10.1016/j.jaad.2021.08.019.
|
[3] |
Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression[J]. Nat Rev Cancer, 2010,10(6):415⁃424. doi: 10.1038/nrc2853.
|
[4] |
Kim KK, Sheppard D, Chapman HA. TGF⁃β1 signaling and tissue fibrosis[J]. Cold Spring Harb Perspect Biol, 2018,10(4):a022293. doi: 10.1101/cshperspect.a022293.
|
[5] |
Zhao M, Wang M, Chen X, et al. Targeting progranulin alleviated silica particles⁃induced pulmonary inflammation and fibrosis via decreasing Il⁃6 and Tgf⁃β1/Smad[J]. J Hazard Mater, 2024,465:133199. doi: 10.1016/j.jhazmat.2023.133199.
|
[6] |
Sanchez⁃Duffhues G, Orlova V, Ten Dijke P. In brief: endothelial⁃to⁃mesenchymal transition[J]. J Pathol, 2016,238(3):378⁃380. doi: 10.1002/path.4653.
|
[7] |
Shi M, Zhu J, Wang R, et al. Latent TGF⁃β structure and activation[J]. Nature, 2011,474(7351):343⁃349. doi: 10.1038/nature10152.
|
[8] |
Liu A, Yu C, Qiu C, et al. PRMT5 methylating SMAD4 activates TGF⁃β signaling and promotes colorectal cancer metastasis[J]. Oncogene, 2023,42(19):1572⁃1584. doi: 10.1038/s41388⁃023⁃02674⁃x.
|
[9] |
Ding J, Yang YY, Li PT, et al. TGF⁃β1/SMAD3⁃driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma[J]. Cancer Lett, 2024,588:216768. doi: 10.1016/j.canlet.2024.216768.
|
[10] |
Dai XY, Zhou L, Huang XR, et al. Smad7 protects against chronic aristolochic acid nephropathy in mice[J]. Oncotarget, 2015,6(14):11930⁃11944. doi: 10.18632/oncotarget.3718.
|
[11] |
杨开颖, 龚雪, 邱桐, 等. 糖酵解关键酶PFKFB3对婴幼儿血管瘤内皮细胞增殖、迁移及凋亡的影响[J]. 中华皮肤科杂志, 2023,56(4):320⁃324. doi: 10.35541/cjd.20220463.
|
[12] |
Xiong J, Kawagishi H, Yan Y, et al. A metabolic basis for endothelial⁃to⁃mesenchymal transition[J]. Mol Cell, 2018,69(4):689⁃698.e7. doi: 10.1016/j.molcel.2018.01.010.
|
[13] |
Xiang S, Gong X, Qiu T, et al. Insights into the mechanisms of angiogenesis in infantile hemangioma[J]. Biomed Pharmacother, 2024,178:117181. doi: 10.1016/j.biopha.2024.117181.
|
[14] |
Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR⁃142⁃3p/miR⁃506⁃3p⁃TGF⁃β1 axis[J]. Mol Cancer, 2020,19(1):117. doi: 10.1186/s12943⁃020⁃01235⁃0.
|
[15] |
Song J, Lv H, Liu B, et al. Let⁃7 suppresses liver fibrosis by inhibiting hepatocyte apoptosis and TGF⁃β production[J]. Mol Metab, 2023,78:101828. doi: 10.1016/j.molmet.2023.101828.
|
[16] |
Zhang L, Xu J, Zhou S, et al. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma[J]. J Hepatol, 2024,80(1):82⁃98. doi: 10.1016/j.jhep.2023. 10.006.
|
[17] |
Sakata M, Kunimoto K, Kawaguchi A, et al. Analysis of cytokine profiles in sera of single and multiple infantile hemangioma[J]. J Dermatol, 2023,50(7):906⁃911. doi: 10.1111/1346⁃8138. 16781.
|
[18] |
Liu S, Ren J, Ten Dijke P. Targeting TGFβ signal transduction for cancer therapy[J]. Signal Transduct Target Ther, 2021,6(1):8. doi: 10.1038/s41392⁃020⁃00436⁃9.
|
[19] |
Derynck R, Turley SJ, Akhurst RJ. TGFβ biology in cancer progression and immunotherapy[J]. Nat Rev Clin Oncol, 2021,18(1):9⁃34. doi: 10.1038/s41571⁃020⁃0403⁃1.
|
[20] |
Sugano T, Masuda M, Takeshita F, et al. Pharmacological blockage of transforming growth factor⁃β signalling by a Traf2⁃ and Nck⁃interacting kinase inhibitor, NCB⁃0846[J]. Br J Cancer, 2021,124(1):228⁃236. doi: 10.1038/s41416⁃020⁃01162⁃3.
|
[21] |
Wu J, He Z, Yang XM, et al. RCCD1 depletion attenuates TGF⁃β⁃induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells[J]. Cancer Lett, 2017,400:18⁃29. doi: 10.1016/j.canlet.2017.04.021.
|
[22] |
Manetti M, Romano E, Rosa I, et al. Endothelial⁃to⁃mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis[J]. Ann Rheum Dis, 2017,76(5):924⁃934. doi: 10.1136/annrheumdis⁃2016⁃210229.
|
[23] |
Huang M, Liu T, Ma P, et al. c⁃Met⁃mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma[J]. J Clin Invest, 2016,126(5):1801⁃1814. doi: 10.1172/JCI84876.
|
[24] |
秦兴军, 袁尉力, 王绪凯. 转化生长因子TGF⁃β在不同时期血管瘤中的表达与肥大细胞的相关性[J]. 中国口腔颌面外科杂志, 2009,7(2):156⁃162.
|
[25] |
Zeng H, Pan T, Zhan M, et al. Suppression of PFKFB3⁃driven glycolysis restrains endothelial⁃to⁃mesenchymal transition and fibrotic response[J]. Signal Transduct Target Ther, 2022,7(1):303. doi: 10.1038/s41392⁃022⁃01097⁃6.
|
[26] |
Trelford CB, Di Guglielmo GM. Canonical and non⁃canonical TGFβ signaling activate autophagy in an ULK1⁃dependent manner[J]. Front Cell Dev Biol, 2021,9:712124. doi: 10.3389/fcell.2021.712124.
|
[27] |
Jena BC, Das CK, Banerjee I, et al. TGF⁃β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation[J]. Exp Cell Res, 2022,417(1):113195. doi: 10.1016/j.yexcr.2022.113195.
|